InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,000.21
(
-1.41%
)
US TECH 100
16,769.60
(
-1.70%
)
Dow Jones
37,939.06
(
-1.36%
)
Brent Oil
86.85
(
-0.43%
)
Bitcoin
63,261.57
(
-1.59%
)
Post# of 13874
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

trader59

Send PM Follow Ignore
Followers 191
Posts 16377
Boards Moderated 8
Alias Born 01/29/2018

trader59

Member Level

Re: the_hoard post# 11889

Wednesday, 12/08/2021 9:35:19 PM

Wednesday, December 08, 2021 9:35:19 PM

Post# of 13874
Because that source has it wrong, dead wrong.

Google is always a friend:

https://www.biospace.com/article/releases/immune-pharma-signs-letter-of-intent-with-b-pint-pharma-b-regarding-license-and-commercializion-of-ceplene-in-latin-america-/

The tip was the 2017 in the link you’ve posted. That deal happened 2 years before the bankruptcy. It is likely the licensing deal passed on to the new owners of Ceplene.

Save some time, just Google up what Chapter 7 is, and you’ll find there is zero “hope” for Immune and its shareholders.

I swear I’ll never use the phrase “you can’t make this stuff up” ever again after being on the OTC. Apparently you can.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up